OncoGenex Announces Completion of Patient Enrollment in the Rainier™ Clinical Trial Evaluating Apatorsen in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer

OncoGenex Announces Completion of Client Registration in the Rainier ™ Professional Test Reviewing Apatorsen in Combo … Today – 11:37 GMT BOTHELL, Wash. and VANCOUVER, British Columbia, Dec. 16, 2014/ PRNewswire/– OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) revealed today that person enrollment has been completed in the Rainier ™ clinical test, [...] Read More